-
In total, 1,326 participants (males: 48.9%) from twelve communities were enrolled in the final analysis. The mean participant age was 83.5 ± 3.1 years, with no significant sex-specific differences. Among all participants, 11.8% were current smokers and 10.2% were current alcohol drinkers. The weight, BMI, WC, FBG, and UA levels of males were significantly higher than those of females (all P < 0.05). The TC, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and TG levels in females were markedly higher than those in males (all P < 0.01). There were no significant differences in DBP, heart rate, and 2-hPG level of males and females (Table 1).
Table 1. Baseline characteristics of the very elderly population
Groups Overall (N = 1,326) Male (n = 645) Female (n = 681) P-values Age, mean ± SD 83.9 ± 3.5 84.0 ± 3.5 83.8 ± 3.5 0.353 Weight, kg, mean ± SD 54.7 ± 11.5 60.2 ± 10.1 49.4 ± 10.2 < 0.001 BMI, kg/m2, mean ± SD 23.0 ± 3.9 23.3 ± 3.6 22.8 ± 4.1 0.022 WC, cm, mean ± SD 88.5 ± 10.5 89.6 ± 10.2 87.5 ± 10.7 < 0.001 Current smoking (%) 157 ± 11.8 112 ± 17.4 45 ± 6.6 < 0.001 Current drinking (%) 135 ± 10.2 118 ± 18.3 17 ± 2.5 < 0.001 SBP, mmHg, mean ± SD 149.3 ± 21.7 147.2 ± 20.1 151.2 ± 23.0 0.001 DBP, mmHg, mean ± SD 74.0 ± 12.1 74.5 ± 11.5 73.7 ± 12.7 0.223 Heart rate/min, mean ± SD 76.1 ± 12.4 76.3 ± 13.7 75.9 ± 11.0 0.487 TC, mmol/L, mean ± SD 4.8 ± 0.9 4.6 ± 0.9 5.0 ± 0.9 < 0.001 HDL-C, mmol/L, mean ± SD 1.6 ± 0.4 1.5 ± 0.4 1.7 ± 0.4 < 0.001 LDL-C, mmol/L, mean ± SD 2.6 ± 0.8 2.5 ± 0.7 2.7 ± 0.8 < 0.001 TG, mmol/L, mean ± SD 1.4 ± 0.7 1.3 ± 0.6 1.4 ± 0.7 < 0.001 FPG, mmol/L, mean ± SD 5.6 ± 2.1 5.8 ± 2.3 5.5 ± 2.0 0.043 2-hPG, mmol/L, mean ± SD 8.6 ± 3.7 8.7 ± 2.8 8.4 ± 4.4 0.238 UA, mmol/L, mean ± SD 334.6 ± 117.7 360.1 ± 118.4 310.4 ± 112.0 < 0.001 Note. BMI, body mass index; WC, waist circumference; DBP, diastolic blood pressure; SBP, systolic blood pressure; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; FPG, fasting plasma glucose; 2-hPG, 2-h plasma glucose; UA, uric acid; SD, standard deviation. -
The overall prevalence of DM was 27.4% (Figure 2). The prevalence of DM in males was 30.2% (195/645), whereas it was 24.7% (168/681) in females (P = 0.02). The prevalence of DM in the very elderly population aged 80–84, 85–89, and ≥ 90 years was 29.8%, 25.9%, and 14.2%, respectively. Overall, the prevalence of DM in the very elderly population negatively correlated with age (P < 0.001) (Figure 3). With regards to BMI, the prevalence of DM was 8.2%, 26.6%, 35.8%, and 41.7% in those with a BMI of < 18.5, 18.5–24.9, 25.0–29.9, and ≥ 30 kg/m2, respectively. Therefore, the prevalence of DM positively correlated with BMI (Figure 4) (P < 0.001).
Of the 363 diabetic patients, 229 had been previously diagnosed, and 134 were newly diagnosed. Newly diagnosed DM cases accounted for 36.9% of all DM patients. The ratio of newly diagnosed DM cases was 42.1% in males and 31.0% in females (P = 0.03). Among the participants aged 80–84 years, 34.6% were newly diagnosed, whereas 50.0% of participants aged ≥ 90 years were newly diagnosed DM cases (Table 2).
Table 2. Diabetes detection in the very elderly population
Parameter Previous diagnosed Newly diagnosed Proportion of newly diagnosed N (%) 229 (17.3) 134 (10.1) 36.9 Gender, n (%) Male 113 (17.5) 82 (12.7) 42.1 Female 116 (17.0) 52 (7.6) 31.0 Age group, n (%) 80–84 195 (19.7) 103 (10.4) 34.6 85–89 29 (11.2) 26 (10.1) 47.3 ≥ 90 5 (6.3) 5 (6.3) 50.0 -
The results of the univariate logistic regression analysis and the ORs and 95% CIs for the different associated factors are shown in Table 3. The results showed that male sex (OR = 1.323; 95% CI, 1.039–1.687), hypertension (OR = 1.543; 95% CI, 1.164–2.064), hypertriglyceridemia (OR = 1.869; 95% CI, 1.259–2.752), overweight or obesity (OR = 1.859; 95% CI, 1.437–2.403), high heart rate (OR = 1.298; 95% CI, 1.019–1.654), and abdominal obesity (OR = 1.823; 95% CI, 1.422–2.346) were all positively correlated with DM. However, age was negatively correlated with DM (OR = 0.943; 95% CI, 0.908–0.978). Next, potential factors related to DM in this very elderly population were included in the multivariate logistic regression model analysis. The results revealed that male sex (OR = 1.433; 95% CI, 1.116–1.843), hypertension (OR = 1.439; 95% CI, 1.079–1.936), overweight or obesity (OR = 1.371; 95% CI, 1.023–1.834), high heart rate (OR = 1.362; 95% CI, 1.063–1.745), and abdominal obesity (OR = 1.615; 95% CI, 1.216–2.149) were all positively correlated with DM, whereas age was negatively correlated with DM (OR = 0.952; 95% CI, 0.916–0.989) (Table 4).
Table 3. Logistic regression for DM among the very elderly population (univariate analysis)
Variable β SE Wald P-value OR 95% CI Age −0.059 0.019 9.632 0.002 0.943 (0.908–0.978) Sex (reference: Female) 0.280 0.124 5.143 0.023 1.323 (1.039–1.687) Hypertension 0.434 0.146 8.840 0.003 1.543 (1.164–2.064) Overweight or obesity (BMI ≥ 25) 0.620 0.131 22.374 < 0.001 1.859 (1.437–2.403) Heart rate (≥ 75 per minute) 0.261 0.124 4.449 0.035 1.298 (1.019–1.654) Center obesity 0.600 0.128 22.105 < 0.001 1.823 (1.422–2.346) Hypertriglyceridemia 0.626 0.199 9.871 0.002 1.869 (1.259–2.752) Note. β, partial regression coefficient; SE, standard error of partial regression coefficient; OR, odds ratio; CI, confidence interval. Table 4. Logistic regression for DM among the very elderly population (multivariable analysis)
Variable β SE Wald P-value OR 95% CI Age −0.0491 0.0196 6.287 0.012 0.952 (0.916–0.989) Sex (reference: Female) 0.360 0.128 7.919 0.005 1.433 (1.116–1.843) Hypertension 0.364 0.149 5.968 0.015 1.439 (1.079–1.936) Overweight or obesity 0.315 0.149 4.488 0.034 1.371 (1.023–1.834) Heart rate (> 75 beats/min) 0.309 0.126 6.000 0.015 1.362 (1.063–1.745) Center obesity 0.480 0.145 10.928 0.001 1.615 (1.216–2.149) Note. β, partial regression coefficient; SE, standard error of partial regression coefficient; OR, odds ratio; CI, confidence interval.
doi: 10.3967/bes2020.043
Prevalence and Associated Factors of Diabetes Mellitus in a Very Elderly Chinese Population: A Cross-sectional Study
-
Abstract:
Objectives This paper aimed to investigate the prevalence of diabetes mellitus (DM) and explore the associated risk factors in a very elderly southwest Chinese population. Methods From September 2015 to June 2016, a cross-sectional survey was conducted to obtain a representative sample of 1,326 participants over 80 years old living in Chengdu. The presence of DM was based on fasting plasma glucose (FPG) and 2-h plasma glucose (2-hPG) levels during an oral glucose tolerance test (OGTT). A logistic regression model was used to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) of the potential associated factors. Results The participants’ mean age was 83.5 ± 3.1 years. The overall prevalence of DM was 27.4%. The prevalence was higher in males (30.2%) than females (24.7%) (P = 0.02). The prevalence of DM increased with body mass index (BMI) and decreased with aging. The multivariate analysis suggested that male sex (OR = 1.433; 95% CI, 1.116–1.843), hypertension (OR = 1.439; 95% CI, 1.079–1.936), overweight or obesity (OR = 1.371; 95% CI, 1.023–1.834), high heart rate (≥ 75 beats/min; OR = 1.362; 95% CI, 1.063–1.746), and abdominal obesity (OR = 1.615; 95% CI, 1.216–2.149) were all significantly positively correlated with DM. However, age was negatively correlated with DM (OR = 0.952; 95% CI, 0.916–0.989). Conclusions The prevalence of DM and newly diagnosed DM in a very elderly southwest Chinese population was high. OGTT screening should be performed regularly in people aged ≥ 80 years to ensure timely diagnosis of DM. -
Key words:
- Diabetes /
- Very Elderly Chinese /
- Prevalence
-
Table 1. Baseline characteristics of the very elderly population
Groups Overall (N = 1,326) Male (n = 645) Female (n = 681) P-values Age, mean ± SD 83.9 ± 3.5 84.0 ± 3.5 83.8 ± 3.5 0.353 Weight, kg, mean ± SD 54.7 ± 11.5 60.2 ± 10.1 49.4 ± 10.2 < 0.001 BMI, kg/m2, mean ± SD 23.0 ± 3.9 23.3 ± 3.6 22.8 ± 4.1 0.022 WC, cm, mean ± SD 88.5 ± 10.5 89.6 ± 10.2 87.5 ± 10.7 < 0.001 Current smoking (%) 157 ± 11.8 112 ± 17.4 45 ± 6.6 < 0.001 Current drinking (%) 135 ± 10.2 118 ± 18.3 17 ± 2.5 < 0.001 SBP, mmHg, mean ± SD 149.3 ± 21.7 147.2 ± 20.1 151.2 ± 23.0 0.001 DBP, mmHg, mean ± SD 74.0 ± 12.1 74.5 ± 11.5 73.7 ± 12.7 0.223 Heart rate/min, mean ± SD 76.1 ± 12.4 76.3 ± 13.7 75.9 ± 11.0 0.487 TC, mmol/L, mean ± SD 4.8 ± 0.9 4.6 ± 0.9 5.0 ± 0.9 < 0.001 HDL-C, mmol/L, mean ± SD 1.6 ± 0.4 1.5 ± 0.4 1.7 ± 0.4 < 0.001 LDL-C, mmol/L, mean ± SD 2.6 ± 0.8 2.5 ± 0.7 2.7 ± 0.8 < 0.001 TG, mmol/L, mean ± SD 1.4 ± 0.7 1.3 ± 0.6 1.4 ± 0.7 < 0.001 FPG, mmol/L, mean ± SD 5.6 ± 2.1 5.8 ± 2.3 5.5 ± 2.0 0.043 2-hPG, mmol/L, mean ± SD 8.6 ± 3.7 8.7 ± 2.8 8.4 ± 4.4 0.238 UA, mmol/L, mean ± SD 334.6 ± 117.7 360.1 ± 118.4 310.4 ± 112.0 < 0.001 Note. BMI, body mass index; WC, waist circumference; DBP, diastolic blood pressure; SBP, systolic blood pressure; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; FPG, fasting plasma glucose; 2-hPG, 2-h plasma glucose; UA, uric acid; SD, standard deviation. Table 2. Diabetes detection in the very elderly population
Parameter Previous diagnosed Newly diagnosed Proportion of newly diagnosed N (%) 229 (17.3) 134 (10.1) 36.9 Gender, n (%) Male 113 (17.5) 82 (12.7) 42.1 Female 116 (17.0) 52 (7.6) 31.0 Age group, n (%) 80–84 195 (19.7) 103 (10.4) 34.6 85–89 29 (11.2) 26 (10.1) 47.3 ≥ 90 5 (6.3) 5 (6.3) 50.0 Table 3. Logistic regression for DM among the very elderly population (univariate analysis)
Variable β SE Wald P-value OR 95% CI Age −0.059 0.019 9.632 0.002 0.943 (0.908–0.978) Sex (reference: Female) 0.280 0.124 5.143 0.023 1.323 (1.039–1.687) Hypertension 0.434 0.146 8.840 0.003 1.543 (1.164–2.064) Overweight or obesity (BMI ≥ 25) 0.620 0.131 22.374 < 0.001 1.859 (1.437–2.403) Heart rate (≥ 75 per minute) 0.261 0.124 4.449 0.035 1.298 (1.019–1.654) Center obesity 0.600 0.128 22.105 < 0.001 1.823 (1.422–2.346) Hypertriglyceridemia 0.626 0.199 9.871 0.002 1.869 (1.259–2.752) Note. β, partial regression coefficient; SE, standard error of partial regression coefficient; OR, odds ratio; CI, confidence interval. Table 4. Logistic regression for DM among the very elderly population (multivariable analysis)
Variable β SE Wald P-value OR 95% CI Age −0.0491 0.0196 6.287 0.012 0.952 (0.916–0.989) Sex (reference: Female) 0.360 0.128 7.919 0.005 1.433 (1.116–1.843) Hypertension 0.364 0.149 5.968 0.015 1.439 (1.079–1.936) Overweight or obesity 0.315 0.149 4.488 0.034 1.371 (1.023–1.834) Heart rate (> 75 beats/min) 0.309 0.126 6.000 0.015 1.362 (1.063–1.745) Center obesity 0.480 0.145 10.928 0.001 1.615 (1.216–2.149) Note. β, partial regression coefficient; SE, standard error of partial regression coefficient; OR, odds ratio; CI, confidence interval. -
[1] Danaei G, Fahimi S, Lu Y, et al. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol, 2015; 3, 624−37. doi: 10.1016/S2213-8587(15)00129-1 [2] Herman WH, Zimmet P. Type 2 Diabetes: an epidemic requiring global attention and urgent action. Diabetes Care, 2012; 35, 943−4. doi: 10.2337/dc12-0298 [3] Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012; 380, 2095−128. doi: 10.1016/S0140-6736(12)61728-0 [4] Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012; 380, 2197−223. doi: 10.1016/S0140-6736(12)61689-4 [5] Su Y, Yuan C, Zhou Z, et al. Impact of an SMS advice programme on maternal and newborn health in rural China: study protocol for a quasi-randomised controlled trial. BMJ Open, 2016; 6, e011016. doi: 10.1136/bmjopen-2015-011016 [6] Pan XR, Yang WY, Li GW, et al. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care, 1997; 20, 1664−9. doi: 10.2337/diacare.20.11.1664 [7] Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia, 2003; 46, 1190−8. doi: 10.1007/s00125-003-1167-8 [8] Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010; 362, 2425−6. doi: 10.1056/NEJMc1004671 [9] Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA, 2017; 317, 2515−23. doi: 10.1001/jama.2017.7596 [10] Liu M, Liu SW, Wang LJ, et al. Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study. Diabetes Metab, 2019; 45, 286−93. doi: 10.1016/j.diabet.2018.08.008 [11] Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract, 2019; 157, 107843. doi: 10.1016/j.diabres.2019.107843 [12] Chentli F, Azzoug S, Mahgoun S. Diabetes mellitus in elderly. Indian J Endocrinol Metab, 2015; 19, 744. doi: 10.4103/2230-8210.167553 [13] Orces CH, Lorenzo C. Prevalence of prediabetes and diabetes among older adults in Ecuador: Analysis of the SABE survey. Diabetes Metab Syndr, 2017; 12, 147−53. [14] Menke A, Casagrande S, Geiss L, et al. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA, 2015; 314, 1021−9. doi: 10.1001/jama.2015.10029 [15] Tones K. Education and Health Promotion: New Direction. Int J Health Promot Educ, 2014; 21, 121−31. [16] Sonoki K, Akifusa S, Fukuhara M, et al. The Impact of Diabetes Mellitus on Mortality in Japanese Individuals Who Are 80 Years Old in the General Population. J Japan Diabetes Soc, 2017; 60, 515−23. [17] Korf ES, Scheltens P, Launer LJ. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care, 2006; 29, 2268. doi: 10.2337/dc06-0243 [18] United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing 2015. https://www.un.org/en/development/desa/population/publications/pdf/ageing/PopulationAgeingAndDevelopment2015.pdf. [2020-3-21] [19] United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing 2019. https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Report.pdf. [2020-3-21] [20] United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects 2019. https://population.un.org/wpp/Download/Files/1_Indicators%20(Standard)/CSV_FILES/WPP2019_PopulationByAgeSex_Medium.csv. [2020-3-21] [21] Zhao Y, Crimmins EM, Hu P, et al. Prevalence, diagnosis, and management of diabetes mellitus among older Chinese: results from the China Health and Retirement Longitudinal Study. Int J Public Health, 2016; 61, 347−56. doi: 10.1007/s00038-015-0780-x [22] Luepker RV, Evans A, Mckeigue P, et al. Cardiovascular survey methods[M]: World Health Organization, 2004. 220-7 . [23] Zhang S, Liu X, Yu Y, et al. Genetic and environmental contributions to phenotypic components of metabolic syndrome: a population‐based twin study. Obesity, 2012; 17, 1581−7. [24] Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998; 15, 539−53. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S [25] Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003; 289, 2560−72. doi: 10.1001/jama.289.19.2560 [26] The International Diabetes Federation. IDF Consensus Worldwide Definition of the Metabolic Syndrome. https://www.idf.org/component/attachments/attachments.html?id = 705&task = download. [2020-3-21] [27] Expert Panel on D, Evaluation, and Treatment of High Blood Cholesterol in A. Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). JAMA, 2001; 285, 2486−97. doi: 10.1001/jama.285.19.2486 [28] Porapakkham Y, Pattaraarchachai J, Aekplakorn W. Prevalence, awareness, treatment and control of hypertension and diabetes mellitus among the elderly: the 2004 National Health Examination Survey III, Thailand. Singapore Med J, 2008; 49, 868. [29] Liu M, Lv X, Li Y, et al. Prevalence and control status of diabetes and related risk factors among 4196 chinese male older elderly aged ≥80 years. Int J Gerontol, 2018; 12, 122−6. doi: 10.1016/j.ijge.2017.08.005 [30] Corsi DJ, Subramanian SV. Association between socioeconomic status and self-reported diabetes in India: a cross-sectional multilevel analysis. BMJ Open, 2012; 2, 1−12. [31] Okwechime IO, Roberson S, Odoi A. Prevalence and predictors of pre-diabetes and diabetes among adults 18 years or older in florida: a multinomial logistic modeling approach. Plos One, 2016; 10, e0145781. [32] Dinca-Panaitescu S, Dinca-Panaitescu M, Bryant T, et al. Diabetes prevalence and income: Results of the Canadian Community Health Survey. Health Policy, 2011; 99, 116−23. doi: 10.1016/j.healthpol.2010.07.018 [33] Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population. Diabetes Care, 2006; 29, 1263. doi: 10.2337/dc06-0062 [34] Anjana RM, Deepa M, Pradeepa R, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol, 2017; 5, 585−96. doi: 10.1016/S2213-8587(17)30174-2 [35] Yuan T, Xue M, Huang XB. Prevalent study of hypertension among elderly people in Chengdu area. Sichuan Medical Journal, 2011; 32, 460−3. (In Chinese) [36] Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest, 2000; 106, 473−81. doi: 10.1172/JCI10842 [37] Zhang X, Shu XO, Xiang YB, et al. Resting heart rate and risk of type 2 diabetes in women. Int J Epidemiol, 2010; 39, 900−6. doi: 10.1093/ije/dyq068 [38] Kim D-I, Yang HI, Park J-H, et al. The association between resting heart rate and type 2 diabetes and hypertension in Korean adults. Heart, 2016; 102, 1757−62. doi: 10.1136/heartjnl-2015-309119 [39] Masuo K, Mikami H, Ogihara T, et al. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens, 1997; 10, 77−83. doi: 10.1016/S0895-7061(96)00303-2 [40] Palatini P, Mos L, Santonastaso M, et al. Resting heart rate as a predictor of body weight gain in the early stage of hypertension. Obesity, 2012; 19, 618−23. [41] Rathod SD, Crampin AC, Musicha C, et al. Glycated haemoglobin A1c (HbA1c) for detection of diabetes mellitus and impaired fasting glucose in Malawi: a diagnostic accuracy study. Bmj Open, 2018; 8, e020972. doi: 10.1136/bmjopen-2017-020972